Manganese X Appoints Globally Renowned Air Infection Solutions Specialist to Subsidiary Advisory Board
Manganese X Appoints Globally Renowned Air
Infection Solutions Specialist to Subsidiary
Advisory Board
Montreal, Quebec--(Newsfile Corp. - October 6, 2020) -
Manganese X Energy Corp. (TSXV: MN)
(FSE: 9SC2) ("Manganese X"
or the
"Company")
, through its
subsidiary, recently acquired a U.S.
patent that provides for a system and method for air purification and disinfection. The company will be
expanding on this timely and relevant technological theme and is pleased to welcome Lino G. Morris, a
globally recognized expert in air quality systems and management.
Martin Kepman, CEO of Manganese X comments, "Lino, as he is known worldwide, is held in extremely
high regard as a leading designer and developer of innovative scientific and healthcare solutions,
biological manufacturing operations and systems design.
He brings a unique blend of talents in both
technology and management demonstrated in a wide range of projects worldwide in the sciences,
product research & development, manufacturing and implementation.
Lino has a reputation with
governments and companies in a dozen countries for rapidly overcoming all obstacles and delivering on
commitments."
For many years starting in 1971, Lino was the Responsible Head and an owner of FDA licensed
facilities that produced both medical products for human use and ran R&D operations to develop and
manufacture a range of both medical therapeutic use and medical laboratory testing products for a wide
variety of the major pharmaceutical companies. He grew the original USA facilities into production
operations in several other countries and expanded his markets to a wide range of international markets.
He is currently the CEO of the PureBiotics
®
Group which started investigating the applications of
probiotics for external healthcare applications in 2007 and in 2008 acquired the exclusive rights for a
European line of probiotic products for North America and a range of other countries and for several
specific applications and expanded research for 'stabilized external use probiotics for environmental
control applications.'
These "StaBiotics"
®
products proved to be a major break-through and a truly "disruptive technology"
with applications that became proven for a wide range solutions from the medical field (where it can
reduce the risk of millions of hospital infections capable of saving countless lives and billions of
healthcare dollars) to home use and for allergy and asthma sufferers (where PureBiotics
®
safely
removes allergens, contaminants and other irritants); for millions with skin problems from blemishes,
acne and rashes to psoriasis (making skin feel and look better while, most important, significantly
lowering the risk of infections); for effectively removing/deconstructing biofilm and that the solutions
keeps working for days, down to the actual microscopic level, providing true ongoing protection and
cleanliness for all facilities from restaurants to homes and from hospitals to farms and animal facilities as
well as thousands of other applications from HVAC to water systems. And, by working at the
microscopic level, it is the world's most effective deodorizer system, providing true odour deconstruction.
Lino, who has specialized in the medical field since the late 1960's, was also the founder and CEO of
the WorldHub group in 1994, which provided unique, "neutral", technology and switching center services
and products, originally for hospital systems, which then grew into the full range of telecommunications
operations and facilities both domestically and internationally, where hundreds of carriers and users
were served from his network of facilities with Centers in New York, Newark, London and Miami (the
photo shows Company's New York Nortel Switch Room).
After selling his interests in WorldHub in January 2005 (though he still directed the Company's London
operations through 2007), Lino returned full time as CEO of the General Sciences Group, where one of
the Company's prime interests from 2001 had been in its Medical Sciences Division was developing
new patents for a non-contact monitoring system.
Additional operations of the Group were providing EcoSense solutions for the removal of hydrocarbons
and other impurities from storm water and many other water contamination sources to a range of clients
from the IPEX Group in Canada to hundreds of installations for the City of Miami. These ecological
systems have successfully been installed in several dozen countries and in many locations from Cape
Kennedy to Sweden. These types of hydrocarbon deconstruction products are currently being added to
the PureBiotics Line as well. Lino was also on the advisory boards of several public companies and has
headed or assisted in the technology operations and international activities for a number of others.
Lino also served for several years as Director of Exchange Services for Interoute, a large European
group that built the newest and largest fiber network in Europe, covering some 300 locations in 16
countries. At that time, Lino was also a partner in a company that acquired 130 communications towers
in 22 States.
For a number of years, Lino headed the Communication Sciences Group, which originally designed
medical systems and then grew into building and installed communications switching and other systems
around the world, initially for hospitals, which evolved to providing neutral stored value and financial
transactions systems and which led to the development of WorldHub.
A contributor to several patents, his background includes authoring numerous publications and he has
been a member of many professional organizations, boards and committees. He has a proven track
record in business and as a consultant in dozens of countries around the world, with clients including a
number of governments and many major international companies.
The company further confirms 500,000 stock options will be granted to Lino Morris
at an exercise price
of $0.50 for a period of three years from the date of grant and vesting immediately.
The Company further announces a correction to its news release dated September 3, 2020 announcing
the closing of its non-brokered private placement for gross proceeds of approximately $2,000,000 (the
"
Private Placement
"). In connection with the private placement, the Company paid finder's fees of an
aggregate of $20,160 and issued compensation warrants for 172,000 common shares at $0.15 per
share for three (3) years from closing. The Company has received final approval of the Private
Placement from the TSX Venture Exchange.
Manganese's X mission is to acquire and advance high potential manganese mining prospects
located in North America with the intent of supplying value added materials to the lithium ion battery
and other alternative energy industries. In addition our company is striving to achieve new
methodologies emanating from environmentally and
geographically ethical and friendly green/zero
emissions technologies, while processing
manganese .at a lower competitive cost. For more
information visit the website at
www.manganesexenergycorp.com
.
On behalf of the Board of Directors of
MANGANESE X ENERGY CORP.
Martin Kepman
CEO and Director
Email:
Tel: 1-514-802-1814
Cautionary Note Regarding Forward-Looking Statements:
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this
release.
This news release contains "forward-looking information" including statements with respect to the
future exploration performance of the Company. This forward-looking information involves known and
unknown risks, uncertainties and other factors which may cause the actual results, performance or
achievements of the Company to be materially different from any future results, performance or
achievements of the Company, expressed or implied by such forward-looking statements. These
risks, as well as others, are disclosed within the Company's filing on SEDAR, which investors are
encouraged to review prior to any transaction involving the securities of the Company. Forward-
looking information contained herein is provided as of the date of this news release and the Company
disclaims any obligation, other than as required by law, to update any forward-looking information for
any reason. There can be no assurance that forward-looking information will prove to be accurate and
the reader is cautioned not to place undue reliance on such forward-looking information. We seek safe
harbor.
NOT FOR DISSEMINATION IN THE US OR THROUGH US NEWSWIRE SERVICES
To view the source version of this press release, please visit
https://www.newsfilecorp.com/release/65266